SB 5371 Washington Senate · 2019-2020 Regular Session

Protecting consumers and purchasers from excessive increases in insulin drug prices.

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2020

Committee Review

Floor Vote

Governor

Introduced Jan 13, 2020 Last action Jan 13, 2020

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jan 13, 2020

Introduced

By resolution, reintroduced and retained in present status.

upper

Feb 4, 2019

Upper · Passed

Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 01:30 PM

upper

Jan 28, 2019

Upper · Passed

Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 01:30 PM

upper

1 primary · 14 co-sponsors

Sponsors

Role

Legislator

Party

State

District